Cargando…

Breakthrough treatment choice for Acute Myeloid Leukemia in pediatric and adult patients: Revumenib, an oral selective inhibitor of KMTA2Ar

Detalles Bibliográficos
Autores principales:	Fareed, Areeba, Inam, Nimrah, Faraz, Fatima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272631/ https://www.ncbi.nlm.nih.gov/pubmed/37333047 http://dx.doi.org/10.1177/20363613231183785

Ejemplares similares

P561: REVUMENIB IN PATIENTS WITH ACUTE LEUKEMIAS: COMPASSIONATE USE PROGRAM EXPERIENCE
por: Rubnitz, Jeffrey, et al.
Publicado: (2023)

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia
por: Issa, Ghayas C., et al.
Publicado: (2023)

1150. Breakthrough Invasive Fungal Disease (IFD) in Patients with Acute Myeloid Leukemia (AML)
por: Wasylyshyn, Anastasia, et al.
Publicado: (2020)

The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia
por: Saydam, Guray, et al.
Publicado: (2022)

Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia
por: Elgamal, Ola A., et al.
Publicado: (2020)

PB2590: BREAKTHROUGH INVASIVE FUNGAL INFECTION CAUSED BY SCEDOSPORIUM APIOSPERMUM IN PEDIATRIC PATIENT WITH ACUTE MYELOID LEUKEMIA: DIAGNOSTIC, CLINICAL COURSE AND TREATMENT
por: Raya, María Pérez, et al.
Publicado: (2023)

Pediatric chronic myeloid leukemia in myeloid blast crisis
por: Dey, Biswajit, et al.
Publicado: (2023)

The Latest Breakthroughs in Immunotherapy for Acute Myeloid Leukemia, with a Special Focus on NKG2D Ligands
por: Maurer, Stefanie, et al.
Publicado: (2022)

Overexpression of annexin A5 might guide the gemtuzumab ozogamicin treatment choice in patients with pediatric acute myeloid leukemia
por: Zhang, Nan, et al.
Publicado: (2020)

Current treatment for pediatric acute myeloid leukemia
por: Im, Ho Joon
Publicado: (2018)

Pediatric acute myeloid leukemia with breast chloromas
por: Gallardo, Maria S., et al.
Publicado: (2023)

Long-Term Effects of Acute Myeloid Leukemia Treatment on the Oral System in a Pediatric Patient
por: Lupi, Saturnino Marco, et al.
Publicado: (2018)

Successful treatment of breakthrough disseminated Trichosporon asahii fungemia in a patient with acute myeloid leukemia receiving itraconazole prophylaxis
por: Karigane, Daiki, et al.
Publicado: (2017)

Incidence and Risk Factors for Breakthrough Invasive Mold Infections in Acute Myeloid Leukemia Patients Receiving Remission Induction Chemotherapy
por: Patel, Heena P, et al.
Publicado: (2019)

Enasidenib: An Oral IDH2 Inhibitor for the Treatment of Acute Myeloid Leukemia
por: Myers, Rebecca A., et al.
Publicado: (2018)

Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
por: Kim, Joon-Tae, et al.
Publicado: (2020)

Therapeutic Choice in Older Patients with Acute Myeloid Leukemia: A Matter of Fitness
por: Palmieri, Raffaele, et al.
Publicado: (2020)

Myeloid Sarcoma Presenting as Brain Tumor in Pediatric Acute Myeloid Leukemia Case
por: Solgun, Hüseyin Avni, et al.
Publicado: (2023)

Breakthroughs and challenges in the management of pediatric viral hepatitis
por: Nicastro, Emanuele, et al.
Publicado: (2021)

Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
por: Tasian, Sarah K., et al.
Publicado: (2014)

Pediatric Acute Myeloid Leukemia—Past, Present, and Future
por: Reinhardt, Dirk, et al.
Publicado: (2022)

Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia
por: Obszański, Piotr, et al.
Publicado: (2022)

Risk-Stratified Therapy for Pediatric Acute Myeloid Leukemia
por: Tomizawa, Daisuke, et al.
Publicado: (2023)

Briumvi: a breakthrough in the treatment of relapsing multiple sclerosis: a review
por: Azhar, Ayesha, et al.
Publicado: (2023)

Oral Manifestations and Complications in Childhood Acute Myeloid Leukemia
por: Cammarata-Scalisi, Francisco, et al.
Publicado: (2020)

1220. Comparing Breakthrough Fungal Infections in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients Receiving Prophylaxis with Different Azoles
por: Chen, Catherine, et al.
Publicado: (2023)

Pediatric Tuberculosis Management: A Global Challenge or Breakthrough?
por: Maphalle, Lehlogonolo N. F., et al.
Publicado: (2022)

Immunophenotypic evolution of blast populations in pediatric acute myeloid leukemia
por: Pereira, Welbert Oliveira, et al.
Publicado: (2016)

Clinical Significance of TARP Expression in Pediatric Acute Myeloid Leukemia
por: Depreter, Barbara, et al.
Publicado: (2020)

Immune receptor repertoires in pediatric and adult acute myeloid leukemia
por: Zhang, Jian, et al.
Publicado: (2019)

Long noncoding RNAs as regulators of pediatric acute myeloid leukemia
por: Neyazi, Sina, et al.
Publicado: (2022)

High-Risk Acute Myeloid Leukemia: A Pediatric Prospective
por: Cacace, Fabiana, et al.
Publicado: (2022)

Epigenetic modifications and targeted therapy in pediatric acute myeloid leukemia
por: Xu, Huan, et al.
Publicado: (2022)

Analysis of rare driving events in pediatric acute myeloid leukemia
por: Noort, Sanne, et al.
Publicado: (2022)

Outcomes of pediatric acute myeloid leukemia treatment in Western Kenya
por: van Weelderen, Romy E., et al.
Publicado: (2021)

＜Editors’ Choice＞ How to improve outcomes of elderly patients with acute myeloid leukemia: era of excitement
por: Naoe, Tomoki
Publicado: (2020)

The Expanding Role of GLP-1: From Diabetes Management to Cancer Treatment
por: Fareed, Areeba, et al.
Publicado: (2023)

Isolated Mediastinal Myeloid Sarcoma after NPM1-Positive Pediatric Acute Myeloid Leukemia
por: Tüfekçi, Özlem, et al.
Publicado: (2019)

Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis
por: Calmettes, Claire, et al.
Publicado: (2018)

Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia
por: Liu, Yuanyuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g3tjdr1932uhjq0bjna7qs7hum